Recruiting Narcolepsy Studies in Miami
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
The purpose of this study is to continue to measure the safety, tolerability, and durability of treatment effect in subjects with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypers...
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepines...
About Narcolepsy Clinical Trials in Miami
Narcolepsy is a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles, causing excessive daytime sleepiness and sudden loss of muscle tone (cataplexy). It is caused by a deficiency of the brain chemical hypocretin. Treatment includes stimulant medications and sodium oxybate.
There are currently 2 narcolepsy clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 352 participants. Research is being sponsored by Alkermes, Inc., Centessa Pharmaceuticals (UK) Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Clinical Trials in Miami — FAQ
Are there narcolepsy clinical trials in Miami?
Yes, there are 2 narcolepsy clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What narcolepsy treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy.
Data updated March 2, 2026 from ClinicalTrials.gov